ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+14.85%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$789M
AUM Growth
+$789M
(+0.94%)
Cap. Flow
-$9.07M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
66.06%
Holding
50
New
7
Increased
12
Reduced
16
Closed
7
Top Buys
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$83.6M |
| 2 |
Amicus Therapeutics
FOLD
|
$10.9M |
| 3 |
Neurocrine Biosciences
NBIX
|
$10.1M |
| 4 |
Ascendis Pharma
ASND
|
$8.05M |
| 5 |
Sangamo Therapeutics
SGMO
|
$7.04M |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$28.3M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$28.3M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$20M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$17.1M |
| 5 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$16.3M |
Sector Composition
| 1 | Healthcare | 65.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $92.6M | 11.69% | 10,488,076 | – | – |
|
|
KITE
2
DELISTED
Kite Pharma, Inc.
KITE
| $83.6M | 10.56% | +806,750 | New | +$83.6M |
|
|
3
Amicus Therapeutics
FOLD
$2.34B
| $59.7M | 7.54% | 5,930,956 +1,083,379 | +22% | +$10.9M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $56M | 7.07% | 400,403 -11,420 | -3% | -$1.6M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $45.5M | 5.74% | 500,789 -89,211 | -15% | -$8.1M |
|
|
MDCO
6
DELISTED
Medicines Co
MDCO
| $42.2M | 5.32% | 1,109,100 -75,900 | -6% | -$2.88M |
|
|
DERM
7
DELISTED
Dermira, Inc.
DERM
| $38.6M | 4.88% | 1,325,000 +122,687 | +10% | +$3.58M |
|
|
TLGT
8
DELISTED
Teligent, Inc
TLGT
| $37.8M | 4.77% | 4,130,800 +339,288 | +9% | +$3.1M |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $34.9M | 4.41% | 4,175,376 +395,376 | +10% | +$3.31M |
|
10
Iovance Biotherapeutics
IOVA
$807M
| $30.5M | 3.85% | 4,151,343 -400,000 | -9% | -$2.94M |
|
|
11
Ascendis Pharma
ASND
$11.8B
| $27.5M | 3.47% | 990,924 +290,000 | +41% | +$8.05M |
|
|
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $23.5M | 2.97% | 860,000 +45,000 | +6% | +$1.23M |
|
13
Pacira BioSciences
PCRX
$1.2B
| $22.2M | 2.81% | 465,818 +55,818 | +14% | +$2.66M |
|
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $17.1M | 2.16% | 614,200 -1,015,800 | -62% | -$28.3M |
|
|
AVEO
15
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $14.7M | 1.86% | 6,632,452 +2,694,422 | +68% | +$5.98M |
|
16
Vanda Pharmaceuticals
VNDA
$279M
| $14.7M | 1.86% | 902,146 +284,946 | +46% | +$4.64M |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $13.2M | 1.66% | 140,700 -213,200 | -60% | -$20M |
|
18
Assembly Biosciences
ASMB
$190M
| $12.5M | 1.58% | 607,162 -89,247 | -13% | -$1.84M |
|
|
AGEN
19
Agenus
AGEN
$133M
| $12.4M | 1.57% | 3,183,828 -185,000 | -5% | -$723K |
|
|
AERI
20
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $12.1M | 1.53% | 230,842 -194,158 | -46% | -$10.2M |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $10.9M | 1.37% | 1,953,525 +350,524 | +22% | +$1.95M |
|
22
Catalyst Pharmaceutical
CPRX
$2.52B
| $10.5M | 1.33% | 3,804,745 | – | – |
|
|
23
Neurocrine Biosciences
NBIX
$13.8B
| $10.1M | 1.27% | +219,500 | New | +$10.1M |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.31M | 1.05% | 2,275,401 -107,800 | -5% | -$393K |
|
|
ALIM
25
DELISTED
Alimera Sciences, Inc.
ALIM
| $8.19M | 1.03% | 5,891,581 +100,000 | +2% | +$139K |
|